- Report
- March 2025
- 92 Pages
China
From €1643EUR$1,800USD£1,396GBP
- Report
- July 2022
- 40 Pages
China
From €2920EUR$3,200USD£2,481GBP
- Report
- April 2021
China
From €2373EUR$2,600USD£2,016GBP
- Report
- October 2023
- 150 Pages
Global
From €4426EUR$4,850USD£3,761GBP
- Report
- March 2024
- 138 Pages
Global
From €2737EUR$2,999USD£2,325GBP
- Report
- May 2024
- 128 Pages
Global
From €5930EUR$6,499USD£5,039GBP
- Report
- May 2024
- 128 Pages
Global
From €5930EUR$6,499USD£5,039GBP
- Report
- May 2024
- 129 Pages
Global
From €5930EUR$6,499USD£5,039GBP
- Report
- May 2024
- 135 Pages
Global
From €5930EUR$6,499USD£5,039GBP
- Report
- May 2024
- 139 Pages
Global
From €5930EUR$6,499USD£5,039GBP
- Report
- May 2024
- 132 Pages
Global
From €5930EUR$6,499USD£5,039GBP
- Report
- May 2024
- 134 Pages
Global
From €5930EUR$6,499USD£5,039GBP
- Report
- May 2024
- 133 Pages
Global
From €5930EUR$6,499USD£5,039GBP
- Report
- May 2024
- 132 Pages
Global
From €5930EUR$6,499USD£5,039GBP
- Report
- May 2024
- 134 Pages
Global
From €5930EUR$6,499USD£5,039GBP
- Report
- May 2024
- 140 Pages
Global
From €5930EUR$6,499USD£5,039GBP
- Report
- May 2024
- 131 Pages
Global
From €5930EUR$6,499USD£5,039GBP
- Report
- May 2024
- 137 Pages
Global
From €5930EUR$6,499USD£5,039GBP
- Report
- May 2024
- 130 Pages
Global
From €5930EUR$6,499USD£5,039GBP
- Report
- May 2024
- 139 Pages
Global
From €5930EUR$6,499USD£5,039GBP

The Antibodies market is a subset of the Immune Disorders Drugs market, which focuses on treatments for conditions related to the immune system. Antibodies are proteins produced by the body to fight off foreign substances, such as bacteria and viruses. They are used to treat a variety of immune-related conditions, including autoimmune diseases, allergies, and cancer. Antibodies can be used in combination with other drugs, such as steroids, to reduce inflammation and improve symptoms. They can also be used to target specific cells or proteins in the body, allowing for more targeted treatments.
The Antibodies market is highly competitive, with a number of companies offering a variety of products. Companies such as AbbVie, Amgen, and Biogen are leading the way in developing and marketing antibodies for the treatment of immune-related conditions. Other companies, such as Genentech and Regeneron, are also active in the market, offering a range of products for different conditions. Show Less Read more